1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Tafamidis
Trade Name:
Vyndaqel
Manufacturer/Distributor:
Pfizer Canada
Classification:
Selective stabilizer of transthyretin - cardiac drug
ATC Class:
N07XX08 - tafamidis
Status:
active
Notice of Compliance (yyyy/mm/dd):
2020/01/20
Date Marketed in Canada (yyyy/mm/dd):
2020/04/07
Presentation:
Capsule: 20 mg. DIN: 0249572
Comments:
For the treatment of adult patients with cardiomyopathy.
Source:
Product monograph
Back to:
Drug Product Listings 
